HHLA2 and lung carcinoma: suggested the gene expression of HHLA2 as the prognostic marker for four types of solid tumors (renal, intrahepatic, gastric, and lung cancers).40 Our results elucidated the substantial oncogenic role of HHLA2 not only for the premalignant stage of CRC but also for CRC prognosis.